Phibro Animal Health (NASDAQ:PAHC) Stock Price Down 6.2%

Phibro Animal Health Co. (NASDAQ:PAHC - Get Free Report) shares fell 6.2% during trading on Thursday . The company traded as low as $16.06 and last traded at $16.12. 14,980 shares were traded during trading, a decline of 90% from the average session volume of 150,607 shares. The stock had previously closed at $17.18.

Analyst Ratings Changes

Separately, StockNews.com raised Phibro Animal Health from a "hold" rating to a "buy" rating in a research report on Tuesday, April 9th.

Phibro Animal Health Stock Performance

The company has a 50 day simple moving average of $13.48 and a 200-day simple moving average of $12.03. The stock has a market capitalization of $716.90 million, a P/E ratio of 46.92, a price-to-earnings-growth ratio of 6.30 and a beta of 0.63. The company has a debt-to-equity ratio of 1.66, a current ratio of 3.12 and a quick ratio of 1.60.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, February 7th. The company reported $0.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.27 by $0.06. Phibro Animal Health had a net margin of 1.51% and a return on equity of 16.67%. The business had revenue of $249.90 million for the quarter, compared to analysts' expectations of $242.91 million. On average, equities analysts forecast that Phibro Animal Health Co. will post 1.12 EPS for the current year.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 26th. Stockholders of record on Wednesday, June 5th will be given a $0.12 dividend. The ex-dividend date is Wednesday, June 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.71%. Phibro Animal Health's dividend payout ratio (DPR) is currently 133.33%.

Institutional Investors Weigh In On Phibro Animal Health

Institutional investors and hedge funds have recently made changes to their positions in the business. China Universal Asset Management Co. Ltd. grew its position in Phibro Animal Health by 358.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 2,357 shares of the company's stock worth $27,000 after acquiring an additional 1,843 shares in the last quarter. Fidelis Capital Partners LLC purchased a new position in shares of Phibro Animal Health in the 1st quarter worth about $46,000. Quest Partners LLC bought a new position in shares of Phibro Animal Health during the 4th quarter valued at about $56,000. Tower Research Capital LLC TRC raised its holdings in shares of Phibro Animal Health by 549.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 8,200 shares of the company's stock valued at $95,000 after buying an additional 6,938 shares in the last quarter. Finally, Nisa Investment Advisors LLC boosted its stake in Phibro Animal Health by 19.2% in the fourth quarter. Nisa Investment Advisors LLC now owns 8,500 shares of the company's stock worth $98,000 after buying an additional 1,370 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company's stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.